paper-with-me

홈 › Papers

Developing a Knowledge Graph Framework for Pharmacokinetic Natural Product-Drug Interactions

2022-09-24 · Sanya B. Taneja, Tiffany J. Callahan, Mary F. Paine, Sandra L. Kane-Gill, Halil Kilicoglu, Marcin P. Joachimiak, Richard D. Boyce

Pharmacokinetic natural product-drug interactions (NPDIs) occur when botanical natural products are co-consumed with pharmaceutical drugs. Understanding mechanisms of NPDIs is key to preventing adverse events. We constructed a knowledge graph framework, NP-KG, as a step toward computational discovery of pharmacokinetic NPDIs. NP-KG is a heterogeneous KG with biomedical ontologies, linked data, and full texts of the scientific literature, constructed with the Phenotype Knowledge Translator framework and the semantic relation extraction systems, SemRep and Integrated Network and Dynamic Reasoning Assembler. NP-KG was evaluated with case studies of pharmacokinetic green tea- and kratom-drug interactions through path searches and meta-path discovery to determine congruent and contradictory information compared to ground truth data. The fully integrated NP-KG consisted of 745,512 nodes and 7,249,576 edges. Evaluation of NP-KG resulted in congruent (38.98% for green tea, 50% for kratom), contradictory (15.25% for green tea, 21.43% for kratom), and both congruent and contradictory (15.25% for green tea, 21.43% for kratom) information. Potential pharmacokinetic mechanisms for several purported NPDIs, including the green tea-raloxifene, green tea-nadolol, kratom-midazolam, kratom-quetiapine, and kratom-venlafaxine interactions were congruent with the published literature. NP-KG is the first KG to integrate biomedical ontologies with full texts of the scientific literature focused on natural products. We demonstrate the application of NP-KG to identify pharmacokinetic interactions involving enzymes, transporters, and pharmaceutical drugs. We envision that NP-KG will facilitate improved human-machine collaboration to guide researchers in future studies of pharmacokinetic NPDIs. The NP-KG framework is publicly available at https://doi.org/10.5281/zenodo.6814507 and https://github.com/sanyabt/np-kg.

📄 PDF Abstract BibTeX arXiv:2209.11950

Code (1)

sanyabt/np-kg 공식 구현

Tasks

Relation Extraction

Similar Papers 제목 키워드 기반

Physical formula enhanced multi-task learning for pharmacokinetics prediction

2024-04-16 · Ruifeng Li, Dongzhan Zhou, Ancheng Shen, Ao Zhang 외

Artificial intelligence (AI) technology has demonstrated remarkable potential in drug dis-covery, where pharmacokinetics plays a crucial role in determining the dosage, safety, and efficacy of new drugs. A major challeng…

Drug DiscoveryMulti-Task LearningPrediction

An Integrated Transfer Learning and Multitask Learning Approach for Pharmacokinetic Parameter Prediction

2018-12-21 · Zhuyifan Ye, Yilong Yang, Xiaoshan Li, Dongsheng Cao 외

Background: Pharmacokinetic evaluation is one of the key processes in drug discovery and development. However, current absorption, distribution, metabolism, excretion prediction models still have limited accuracy. Aim: T…

Drug DiscoveryParameter PredictionTransfer Learning

Dynamic Graph Neural Networks for Physiological Based Pharmacokinetic Modeling: A Novel Data Driven Approach to Drug Concentration Prediction

2025-10-25 · Su Liu, Xin Hu, Shurong Wen, Chengyi Chen 외 arxiv

Physiologically Based Pharmacokinetic (PBPK) modeling is a key tool in drug development for predicting drug concentration dynamics across organs. Traditional PBPK approaches rely on ordinary differential equations with s…

Graph Neural Network

AI-Powered Prediction of Nanoparticle Pharmacokinetics: A Multi-View Learning Approach

2025-03-18 · Amirhossein Khakpour, Lucia Florescu, Richard Tilley, Haibo Jiang 외

The clinical translation of nanoparticle-based treatments remains limited due to the unpredictability of (nanoparticle) NP pharmacokinetics$\unicode{x2014}$how they distribute, accumulate, and clear from the body. Predic…

Drug DiscoveryEnsemble Learningfeature selectionMULTI-VIEW LEARNING

A non-parametric optimal design algorithm for population pharmacokinetics

2025-02-20 · Markus Hovd, Alona Kryshchenko, Michael N. Neely, Julian Otalvaro 외

This paper introduces a non-parametric estimation algorithm designed to effectively estimate the joint distribution of model parameters with application to population pharmacokinetics. Our research group has previously d…